Literature DB >> 2969949

Hypothermia induced by m-trifluoromethylphenylpiperazine or m-chlorophenylpiperazine: an effect mediated by 5-HT1B receptors?

J Maj1, E Chojnacka-Wójcik, A Kłodzińska, A Dereń, E Moryl.   

Abstract

In the present study we examined the effect of different drugs on the m-trifluoromethylphenylpiperazine (TFMPP)- and m-chlorophenylpiperazine (m-CPP)-induced hypothermia in mice. Both the hypothermias studied are blocked or reversed by pindolol, cyanopindolol and compound 21-009, but not by atenolol. Neither hypothermia is antagonized by 5-HT1A antagonists (ipsapirone, spiperone), a 5-HT1C antagonist (mesulergine), 5-HT2 antagonists (cyproheptadine, mianserin, methysergide), 5-HT3 antagonists (ICS 205930, metoclopramide). The examined hypothermias are not antagonized by other antihypothermic agents (pimozide, idazoxan, atropine). The 8-OH-DPAT-induced hypothermia is not affected by cyanopindolol or compound 21009. The obtained results indicate that the TFMPP- and m-CPP-induced hypothermias in mice are mediated by 5-HT1B. These hypothermias may be a good screening test for evaluation of the 5-HT1B-agonistic and 5-HT1B-antagonistic activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2969949     DOI: 10.1007/bf01244621

Source DB:  PubMed          Journal:  J Neural Transm            Impact factor:   3.575


  35 in total

1.  Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

Authors:  B P Richardson; G Engel; P Donatsch; P A Stadler
Journal:  Nature       Date:  1985 Jul 11-17       Impact factor: 49.962

2.  A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.

Authors:  G M Goodwin; A R Green
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

3.  The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.

Authors:  G M Goodwin; R J De Souza; A R Green
Journal:  Neuropharmacology       Date:  1985-12       Impact factor: 5.250

4.  beta-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain.

Authors:  A Pazos; G Engel; J M Palacios
Journal:  Brain Res       Date:  1985-09-23       Impact factor: 3.252

5.  Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821.

Authors:  J Traber; M A Davies; W U Dompert; T Glaser; T Schuurman; P R Seidel
Journal:  Brain Res Bull       Date:  1984-06       Impact factor: 4.077

6.  Determination of selective and nonselective compounds for the 5-HT 1A and 5-HT 1B receptor subtypes in rat frontal cortex.

Authors:  M A Sills; B B Wolfe; A Frazer
Journal:  J Pharmacol Exp Ther       Date:  1984-12       Impact factor: 4.030

7.  The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.

Authors:  M D Tricklebank; C Forler; J R Fozard
Journal:  Eur J Pharmacol       Date:  1984-11-13       Impact factor: 4.432

8.  Blockade of serotonin receptors on autonomic neurones by (-)-cocaine and some related compounds.

Authors:  J R Fozard; A T Mobarok Ali; G Newgrosh
Journal:  Eur J Pharmacol       Date:  1979-11-16       Impact factor: 4.432

9.  Serotonin autoreceptor in rat hippocampus: pharmacological characterization as a subtype of the 5-HT1 receptor.

Authors:  G Maura; E Roccatagliata; M Raiteri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-12       Impact factor: 3.000

10.  Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain.

Authors:  N W Pedigo; H I Yamamura; D L Nelson
Journal:  J Neurochem       Date:  1981-01       Impact factor: 5.372

View more
  9 in total

1.  Involvement of 5-HT1B receptors in the anticonflict effect of m-CPP in rats.

Authors:  E Chojnacka-Wójcik; A Kłodzińska
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Involvement of central beta-adrenoceptors in the regulation of yawning responses.

Authors:  K Yamada; S Matsumoto; M Nagashima; M Kumagai; H Kimura; T Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

3.  Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.

Authors:  K B Troelsen; E Ø Nielsen; N R Mirza
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Effects of sertraline and citalopram given repeatedly on the responsiveness of 5-HT receptor subpopulations.

Authors:  J Maj; E Moryl
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  Buspirone does not produce a 5-HT1A-mediated decrease in temperature in man.

Authors:  H S Lee; H Y Meltzer
Journal:  J Neural Transm Gen Sect       Date:  1991

6.  Hyperthermia induced by m-trifluoromethylphenylpiperazine (TFMPP) or m-chlorophenylpiperazine (m-CPP) in heat-adapted rats.

Authors:  A Kłodzińska; E Chojnacka-Wójcik
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

7.  Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in mice.

Authors:  A Lecci; F Borsini; A Mancinelli; V D'Aranno; M A Stasi; G Volterra; A Meli
Journal:  J Neural Transm Gen Sect       Date:  1990

8.  Potentiation of yawning responses to the dopamine receptor agonists B-HT 920 and SND 919 by pindolol in the rat.

Authors:  K Yamada; S Matsumoto; M Nagashima; K Shirakawa; T Furukawa
Journal:  J Neural Transm Gen Sect       Date:  1990

9.  Design, Synthesis, and Biological Evaluation of a Series of 5- and 7-Hydroxycoumarin Derivatives as 5-HT1A Serotonin Receptor Antagonists.

Authors:  Kinga Ostrowska; Anna Leśniak; Zuzanna Czarnocka; Jagoda Chmiel; Magdalena Bujalska-Zadrożny; Bartosz Trzaskowski
Journal:  Pharmaceuticals (Basel)       Date:  2021-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.